Skip to main content
Rural Health Information Hub

FDA: Revocation of Six Authorizations of Emergency Use of In Vitro Diagnostic Device for Detection and/or Diagnosis of COVID-19; Availability

Federal Register
Mar 21, 2024
The Food and Drug Administration (FDA) has revoked 6 Emergency Use Authorizations issued to Life Technologies Corp.; Bio-Rad Laboratories, Inc.; Revvity, Inc.; bioMérieux SA; and Luminex Corp. related to COVID-19 detection and diagnosis tests.
Tagged as
COVID-19 · Legislation and regulations · Pharmacy and prescription drugs